Need Help?

CNV detection in targeted NGS panel data

The aim of this study was to compare copy-number-variation (CNV) detection methods for targeted NGS panel data in a clinical diagnostic setting. We present targeted NGS panel data from 170 samples that were processed using the TruSight(TM) Cancer (TSC) panel (Illumina, San Diego, CA, USA), which targets 94 genes and 284 SNPs associated with a predisposition towards cancer. The samples are enriched for CNVs in the genes of interest. All CNVs have previously been assessed with MLPA and can therefore be considered as confirmed.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00001003400 Illumina MiSeq 170
Publications Citations
panelcn.MOPS: Copy-number detection in targeted NGS panel data for clinical diagnostics.
Hum Mutat 38: 2017 889-897
47
Evaluation of CNV detection tools for NGS panel data in genetic diagnostics.
Eur J Hum Genet 28: 2020 1645-1655
50
BRACNAC: A <i>BRCA1</i> and <i>BRCA2</i> Copy Number Alteration Caller from Next-Generation Sequencing Data.
Int J Mol Sci 24: 2023 16630
0
Detection of germline CNVs from gene panel data: benchmarking the state of the art.
Brief Bioinform 26: 2024 bbae645
0